Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy.
Waller
J R
JR
Division of Transplant Surgery, Leicester General Hospital, Cuenden Road, Leicester LE5 4PW, United Kingdom.
Murphy
G J
GJ
Metcalfe
M S
MS
Sandford
R M
RM
Pattenden
C J
CJ
Nicholson
M L
ML
D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005355:Fibrosis / Q000517:prevention & control*; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus